Last news
Qualcomm Highlights Edge AI Innovation at Qualcomm AI Program for Innovators (QAIPI) 2025 - APAC Demo Day and Sets the Stage for 2026

Qualcomm Highlights Edge AI Innovation at Qualcomm AI Program for Innovators (QAIPI) 2025 - APAC Demo Day and Sets the Stage for 2026

Showcasing transformative edge AI innovations across robotics, healthcare and smart city solutions SEOUL, South Korea, Dec. 8, 2025 /PRNewswire/ -- Qualcomm Technologies, Inc. hosted the Qualcomm AI Program for Innovators (QAIPI) 2025 – APAC Demo...

Elevate Your Family Escape with Upgraded Facilities at Four Points by Sheraton Bali, Kuta

Elevate Your Family Escape with Upgraded Facilities at Four Points by Sheraton Bali, Kuta

BALI, Indonesia, Dec. 8, 2025 /PRNewswire/ -- Planning a family holiday in Kuta? Four Points by Sheraton Bali, Kuta is a 4-star hotel that combines tropical vibes, family-friendly comfort, and warm hospitality. Conveniently located in the heart of...

AGIBOT Announces the Rollout of Its 5,000th Mass-Produced Humanoid Robot

AGIBOT Announces the Rollout of Its 5,000th Mass-Produced Humanoid Robot

SHANGHAI, Dec. 8, 2025 /PRNewswire/ -- AGIBOT, a leading robotics company specializing in embodied intelligence, today announces the official roll-out of its 5,000th mass-produced humanoid robot at its factory. This milestone represents a step...

Beyond Boundaries: How A Redesigned Website Elevates User's Experience

Beyond Boundaries: How A Redesigned Website Elevates User's Experience

HEFEI, China, Dec. 8, 2025 /PRNewswire/ -- Sungrow, the global leading PV inverter and energy storage system provider, successfully launched its global website on December 5th, demonstrating strong digital marketing capabilities and establishing a...

UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder

UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder

Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction in countable motor seizure frequency (CMSF) compared with placebo1 Holistic benefit: secondary endpoints showed significant...

Connexus Travel Launches FIFA World Cup 26™ Content Series

Connexus Travel Launches FIFA World Cup 26™ Content Series

Multi-platform rollout featuring match analysis, player profiles, team previews and travel guides as World Cup excitement intensifies post-draw HONG KONG, Dec. 8, 2025 /PRNewswire/ -- Connexus Travel today announces the launch of its dedicated FIFA...

GC Biopharma Ships First Doses of World's First Recombinant Anthrax Vaccine, 'BARYTHRAX inj.'

GC Biopharma Ships First Doses of World's First Recombinant Anthrax Vaccine, 'BARYTHRAX inj.'

- First anthrax vaccine developed using recombinant DNA technology - Annual production capacity of up to 10 million doses at GC Biopharma's facility YONGIN, South Korea, Dec. 8, 2025 /PRNewswire/ -- GC Biopharma (006280.KS), a leading global...

ASUS IoT and CTHINGS.CO Forge Partnership to Accelerate Scalable Edge AI and IoT Solutions

ASUS IoT and CTHINGS.CO Forge Partnership to Accelerate Scalable Edge AI and IoT Solutions

Smart connectivity made simple with scalable edge AI and 5G-ready IoT solutions KEY POINTS Unified edge intelligence: ASUS IoT gateways and CTHINGS.CO Orchestra enable faster, more secure, and easily managed IoT deployment Smarter operations:...

1 ... 107 108 109 110 111 112 113 114 115 ... 3393
menu
menu